Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583297 · ClinicalTrials.gov registry record
Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial
A clinical trial of Cardiovascular Diseases and Ventricular Tachycardia, sponsored by CardioDx.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT00583297 is a study of Cardiovascular Diseases and Ventricular Tachycardia that has completed, run by CardioDx. The registered enrollment target is 400 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00583297, a study of Cardiovascular Diseases and Ventricular Tachycardia, has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The ABCD clinical study (ClinicalTrials.gov Identifier NCT00187291) was designed to determine if a T-Wave Alternans (TWA) test is equivalent to an Electrophysiology Study (EPS) in predicting life-threatening heart rhythms in patients with ischemic heart disease, left ventricular dysfunction, and non-sustained tachycardia. The purpose of the ABCD Genetic sub-study is to identify genetic markers that predict TWA status and arrhythmia risk in this same population.
Conditions Studied
Study Locations (1)
Ohio
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00583297
The ClinicalTrials.gov registry entry for NCT00583297 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is CardioDx, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00583297 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00583297 about?
NCT00583297 is a clinical study titled "Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial". The ABCD clinical study (ClinicalTrials.gov Identifier NCT00187291) was designed to determine if a T-Wave Alternans (TWA) test is equivalent to an Electrophysiology Study (EPS) in predicting life-threatening heart rhythms in patients with ischemic heart disease, left ventricular dysfunction, and non...
What is the current status of trial NCT00583297?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2007-01. Estimated completion is 2009-12.
What conditions does trial NCT00583297 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Ventricular Tachycardia, Arrythmia, CVD.
Who is sponsoring clinical trial NCT00583297?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00583297 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.